Capstone Holding Corp. 8-K

What Happened Capstone Holding Corp. (CAPS) filed an 8-K reporting that Nasdaq notified the company on January 7, 2026 that the closing bid price of its common stock had been below the $1.00 minimum required for continued listing under Nasdaq Listing Rule 5550(a)(2). Under Nasdaq Listing Rule 5810(c)(3)(a) the company was given 180 days—until July 6, 2026—to regain compliance. On July 8, 2026 Nasdaq informed Capstone it is eligible for an additional 180-day compliance period, extending the deadline to January 4, 2027. If compliance is not regained by that date, Nasdaq will notify the company that its common stock will be delisted; Capstone may appeal to a Nasdaq Hearings Panel.

Key Details

• Initial deficiency notice received: January 7, 2026 (closing bid below $1.00 for 30 consecutive business days).
• Initial cure period: 180 days under Nasdaq Rule 5810(c)(3)(a), deadline July 6, 2026.
• Extension granted: additional 180 days, new deadline January 4, 2027 (notice received July 8, 2026).
• Possible outcomes: Nasdaq-delisting notice if noncompliant after Jan 4, 2027; company may appeal. The company said it may consider options to regain compliance but gave no assurance it will succeed.

Why It Matters This notice signals a real risk that Capstone’s common stock could be delisted from The Nasdaq Capital Market if the company does not restore a closing bid price of at least $1.00 by the extended deadline. Delisting can reduce liquidity, limit investor access, and affect the stock’s marketability. Investors should monitor the stock price, any company actions to cure the deficiency (e.g., corporate actions or communications), and subsequent SEC or Nasdaq filings for updates. The 8-K also includes standard forward-looking statement disclaimers; the company did not commit to a specific cure action.